Guidelines Outline Hypertensive Therapy

JULY 01, 2004

New guidelines released by the National Kidney Foundation state that 20 million American adults with chronic kidney disease (CKD) should be considered in the highest risk group for developing cardiovascular disease. The guidelines, "Hypertension and Antihypertensive Agents in Chronic Kidney Disease," reported in the American Journal of Kidney Disease (May 2004), suggested that physicians can stabilize their kidney patients by reducing blood pressure levels to a maximum of 130/80 mm Hg.

The guidelines provide an integrated clinical action plan; key suggestions include:

  • Blood pressure goal of 130/80 mm Hg is appropriate for all stages of CKD
  • Protein in the urine, in addition to blood pressure, should be monitored to assess the response to antihypertensive agents
  • Lifestyle modifications to lower blood pressure and reduce cardiovascular disease risk should be recommended to all CKD patients


SHARE THIS SHARE THIS
0

Conference Coverage from ASHP Summer 2017 

Four years after they first launched the Summer Meetings in Minneapolis, Minn., the ASHP 2017 Summer Meetings and Exhibition was in Minneapolis once again.  

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.